Early Bone Marrow Examination, On The Fifth Day Of Induction For AML, Is Highly Predictive Of Response
Yishai Ofran(Shaare Zedek Medical Center), Jacob M. Rowe(Technion – Israel Institute of Technology), Tsila Zuckerman(Johannes Gutenberg University Mainz), Netanel A. Horowitz(Rambam Health Care Campus), Sharon Gino‐Moor(Bnai Zion Medical Center), Benjamin Brenner(Rambam Health Care Campus), Ariela Arad(Laniado Hospital), Ariella Tvito(Shaare Zedek Medical Center), Ilana Hellmann(Meir Medical Center), Ronit Leiba(Rambam Health Care Campus), Revital Saban(Shaare Zedek Medical Center), Chezi Ganzel(Shaare Zedek Medical Center), Michal Hayun(Rambam Health Care Campus), Shlomo Bulvik(Laniado Hospital), Israel Henig(Rush University Medical Center), Elinor Sabag(Rambam Health Care Campus), Adi Klil(Rambam Health Care Campus), Alaa Khatib(Rambam Health Care Campus), Noa Lavi(Rambam Health Care Campus), Moshe E. Gatt(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Ron Hoffman, Noam Benyamini(Tel Aviv University)
Cited by 2
Related Papers
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Anthracycline Dose Intensification in Acute Myeloid Leukemia
|New England Journal of Medicine|2009|907
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859